^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    Bio-Rad

    i
    Other names: Bio-Rad Laboratories, Inc. | Bio-Rad Laboratories | Bio-Rad | Bio-Rad Laboratories, Inc | Bio-Rad Laboratories Inc. | Bio-Rad Laboratories Inc. | Bio-Rad Laboratories India Pvt. Ltd. | Bio-Rad Laboratories India Pvt. Ltd., | Celsee Diagnostics | Celsee, Inc | Celsee Inc | Ciphergen Bio
    Related tests:
    Evidence

    News

    9ms
    Bio-Rad and Allegheny Health Network Cancer Institute partner to advance personalized monitoring of solid tumor cancers with droplet digital PCR (Bio-rad Press Release)
    "Bio-Rad Laboratories, Inc...announces a collaboration with Allegheny Health Network (AHN)...This research collaboration aims to generate clinical evidence across a range of cancer types to support the implementation of Bio-Rad’s Droplet Digital™ PCR (ddPCR™) technology for tumor-informed molecular residual disease (MRD) monitoring of patients with solid tumor cancer following curative-intent treatment."
    Licensing / partnership
    9ms
    Bio-Rad launches first ultrasensitive multiplexed digital PCR assay for breast cancer mutation detection in clinical research (Bio-rad Press Release)
    "Bio-Rad Laboratories, Inc...announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ESR1 Mutation Detection Kit. The assay expands the company’s Droplet Digital PCR (ddPCR™) offering for the oncology market, where highly sensitive and multiplexed mutation detection assays aid translational research, therapy selection, and disease monitoring."
    Launch
    over1year
    Bio-Rad and QIAGEN announce patent settlement and cross-licensing agreement (Qiagen)
    "Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the companies have agreed to settle their patent dispute pending in the U.S. District Court of Delaware pursuant to a global settlement and patent cross-licensing agreement relating to digital PCR technology."
    Patent